General Hospital Psychiatry
Volume 32, Issue 3 , Pages 255-261 , May 2010

Quality of care for heart failure among disabled Medicaid recipients with and without severe mental illness

  • Saul Blecker, M.D.

      Affiliations

    • Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    • Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD 21287, USA
    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    • Corresponding Author InformationCorresponding author. Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA, Tel.: +1 410 614 6464; fax: +1 410 955 0476.
    • ,
  • Yiyi Zhang, M.H.S.

      Affiliations

    • Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD 21287, USA
    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    • ,
  • Daniel E. Ford, M.D., M.P.H.

      Affiliations

    • Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    • Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD 21287, USA
    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    • Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    • Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    • ,
  • Eliseo Guallar, M.D., Dr.Ph.

      Affiliations

    • Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD 21287, USA
    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    • ,
  • Susan dosReis, Ph.D.

      Affiliations

    • Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    • Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    • ,
  • Donald M. Steinwachs, Ph.D.

      Affiliations

    • Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    • Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    • Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    • Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    • ,
  • Lisa B. Dixon, M.D., M.P.H.

      Affiliations

    • Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    • ,
  • Gail L. Daumit, M.D., M.H.S.

      Affiliations

    • Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    • Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD 21287, USA
    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    • Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    • Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    • Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

Received 3 December 2009 ,Accepted 3 February 2010.

References 

  1. Curkendall SM, Mo J, Glasser DB, Rose Stang M, Jones JK. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry. 2004;65:715–720
  2. McDermott S, Moran R, Platt T, Isaac T, Wood H, Dasari S. Heart disease, schizophrenia, and affective psychoses: epidemiology of risk in primary care. Community Ment Health J. 2005;41:747–755
  3. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21–181
  4. Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA. 2007;298:1794–1796
  5. Miller BJ, Paschall CB, Svendsen DP. Mortality and medical momorbidity among patients with serious mental illness. Psychiatr Serv. 2006;57:1482–1487
  6. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212–217
  7. Osby U, Brandt L, Correia N, Ekbom A, Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58:844–850
  8. Goldberg RW, Kreyenbuhl JA, Medoff DR, Dickerson FB, Wohlheiter K, Fang LJ, et al. Quality of diabetes care among adults with serious mental illness. Psychiatr Serv. 2007;58:536–543
  9. Kreyenbuhl J, Dickerson FB, Medoff DR, Brown CH, Goldberg RW, Fang L, et al. Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness. J Nerv Ment Dis. 2006;194:404–410
  10. Druss BG, Bradford WD, Rosenheck RA, Radford MJ, Krumholz HM. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry. 2001;58:565–572
  11. Rathore SS, Wang Y, Druss BG, Masoudi FA, Krumholz HM. Mental disorders, quality of care, and outcomes among older patients hospitalized with heart failure: an analysis of the national heart failure project. Arch Gen Psychiatry. 2008;65:1402–1408
  12. Bonow RO, Bennett S, Casey DE, Ganiats TG, Hlatky MA, Konstam MA, et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol. 2005;46:1144–1178
  13. HCUP CCS . Healthcare Cost and Utilization Project (HCUP). Rockville (MD): Agency for Healthcare Research and Quality; 2009;www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp
  14. Curtis LH, Greiner MA, Hammill BG, Kramer JM, Whellan DJ, Schulman KA, et al. Early and long-term outcomes of heart failure in elderly persons, 2001-2005. Arch Intern Med. 2008;168:2481–2488
  15. Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA. 2000;283:506–511
  16. Kilbourne AM, Welsh D, McCarthy JF, Post EP, Blow FC. Quality of care for cardiovascular disease-related conditions in patients with and without mental disorders. J Gen Intern Med. 2008;23:1628–1633
  17. Whyte S, Penny C, Phelan M, Hippisley-Cox J, Majeed A. Quality of diabetes care in patients with schizophrenia and bipolar disorder: cross-sectional study. Diabet Med. 2007;24:1442–1448
  18. Weiss AP, Henderson DC, Weilburg JB, Goff DC, Meigs JB, Cagliero E, et al. Treatment of cardiac risk factors among patients with schizophrenia and diabetes. Psychiatr Serv. 2006;57:1145–1152
  19. Goldman LE, Vittinghoff E, Dudley RA. Quality of care in hospitals with a high percent of Medicaid patients. Med Care. 2007;45:579–583
  20. Pamboukian SV, Nisar I, Patel S, Gu L, McLeod M, Costanzo MR, et al. Factors associated with non-adherence to therapy with warfarin in a population of chronic heart failure patients. Clin Cardiol. 2008;31:30–34
  21. Werner RM, Goldman LE, Dudley RA. Comparison of change in quality of care between safety-net and non-safety-net hospitals. JAMA. 2008;299:2180–2187
  22. Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol. 2003;41:56–61
  23. Bertoni AG, Duren-Winfield V, Ambrosius WT, McArdle J, Sueta CA, Massing MW, et al. Quality of heart failure care in managed Medicare and Medicaid patients in North Carolina. Am J Cardiol. 2004;93:714–718
  24. Deswal A, Petersen NJ, Urbauer DL, Wright SM, Beyth R. Racial variations in quality of care and outcomes in an ambulatory heart failure cohort. Am Heart J. 2006;152:348–354
  25. Yancy C.W., Fonarow G.C., Albert N.M., Curtis A.B., Stough W.G., Gheorghiade M., et al., Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J 2009;157:754,62.e2.
  26. Howard PA, Shireman TI. Heart failure drug utilization patterns for Medicaid patients before and after a heart failure-related hospitalization. Congest Heart Fail. 2005;11:124–128
  27. Zingmond DS, Wilber KH, Maclean CH, Wenger NS. Measuring the quality of care provided to community dwelling vulnerable elders dually enrolled in Medicare and Medicaid. Med Care. 2007;45:931–938
  28. O'Connor CM, Jiang W, Kuchibhatla M, Mehta RH, Clary GL, Cuffe MS, et al. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med. 2008;168:2232–2237
  29. Friedmann E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb SS, et al. Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J 2006;152:940.e1, 940.e8.
  30. Albert NM, Fonarow GC, Abraham WT, Gheorghiade M, Greenberg BH, Nunez E, et al. Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. Am J Med. 2009;122:366–373
  31. Jiang W, Kuchibhatla M, Cuffe MS, Christopher EJ, Alexander JD, Clary GL, et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation. 2004;110:3452–3456
  32. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007;297:61–70
  33. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA. 1995;273:1450–1456
  34. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004;43:317–327
  35. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296:2209–2216
  36. Bagchi AD, Esposito D, Kim M, Verdier J, Bencio D. Utilization of, and adherence to, drug therapy among Medicaid beneficiaries with congestive heart failure. Clin Ther. 2007;29:1771–1783
  37. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009;25:2303–2310
  38. Esposito D, Bagchi AD, Verdier JM, Bencio DS, Kim MS. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs. Am J Manag Care. 2009;15:437–445
  39. Trewet CB, Shireman TI, Rigler SK, Howard PA. Do ACE inhibitors/angiotensin II type 1 receptor antagonists reduce hospitalisations in older patients with heart failure? A propensity analysis. Drugs Aging. 2007;24:945–955

☆ Funding Sources: Dr. Blecker was supported by National Heart, Lung, and Blood Institute grant 5T32HL007024. Dr. Daumit was supported by National Institute of Mental Health grant R01-MH074070.

PII: S0163-8343(10)00018-6

doi: 10.1016/j.genhosppsych.2010.02.002

General Hospital Psychiatry
Volume 32, Issue 3 , Pages 255-261 , May 2010

Article Tools

* Image Usage & Resolution